In 2016, Prof. A. Bechthold (University of Freiburg) and Prof H. Pfundner (Roche Pharma AG) created the idea of a new specialty line “Regulatory Affairs & Drug Development” within the existing Master’s degree program in Pharmaceutical Sciences. There is a need in the industry for university graduates with sound knowledge in the areas of pharmaceutical drug development and regulatory affairs. These topics are usually underrepresented in existing pharmacy degree programs. As a result, pharmacy graduates have difficulties finding employment within these areas of the pharmaceutical industry. Following the creation of the specialty “Regulatory Affairs & Drug Development ”, the association, Academia Meets Industry e.V” was founded at the end of 2017. The major aim of this organization is to support talented young students in their education and facilitate a network between students, university personnel and industry representatives.
Please find below some information about the Board of Academia Meets Industry e.V. and the founding members.
Full Professor at the Institute for Pharmaceutical Sciences and Chair of Pharmaceutical Biology and Biotechnology
Andreas Bechthold was appointed Professor at the Albert-Ludwigs-Universität, Freiburg in 2001. After studying Pharmaceutical Sciences he completed his Ph.D. in the area of natural product biosynthesis at the University of Bonn. In 1992, he became a Postdoctoral Fellow in Seattle, USA and in 1993, a Postdoctoral Fellow in Kyoto, Japan. After his habilitation (1999) at the University in Tübingen, he was appointed to the University of Kiel. In 2001, he moved to Freiburg. Prof. Bechthold is married and has three children. Time spent with his family is most important to him. He hates arrogance and likes dedicated people.
Friederike Zahm brings 25 years of experience from the pharmaceutical industry to this organization. She studied pharmacy at the University of Saarbrücken and gained a PhD at the University of Basel working in virology and pharmacology. In 1986 she joined Roche in Norway and subsequently moved to the Basel headquarters where she held various senior positions within clinical development and global product strategy. She was a member of the board of directors for a Freiburg based Biotech Company between 2010 and 2012 and served as an advisory board member at the Landesstiftung Baden Württemberg in 2009/2010. In 2016 she left Roche to begin work as a consultant to both biotech and pharmaceutical companies. Friederike is married and lives with her husband and their dog, a lively fox terrier, in Freiburg. She is also engaged in local politics. She is a literature junky and reads whenever time allows.
Dr. Helmut Laaff
Helmut Laaff has been running the private DermatoHistological Laboratory (DHL) in Freiburg since 1992. Over the years, the portfolio expanded to include methods of general pathology, hematopathology and molecular pathology. Consequently, in 2020 the DermatoHistological Laboratory changed its name to the Institute for Dermatohistology Pathology Molecular Pathology Dr. Helmut Laaff.
Helmut Laaff initially studied medicine in Tübingen and Rio de Janeiro. He completed his medical residency at the Institute of Clinical Pathology and the Department of Dermatology and Venereology in Freiburg. Afterwards he stayed abroad in NYC to specialize as a dermatopathologist.
In his free time, he enjoys skiing and mountaineering. In 2012, he climbed the Seven Summits – the highest mountain on each of the seven continents.
PhD in pharmacy from the University of Kiel.
He started to work for Hoffmann-La Roche in 1992. He held various senior positions in Europe and North America. Since 2006, CEO Roche Pharma AG Germany and „Geschäftsführer“ Roche Deutschland Holding GmbH. He is a Member of the Board of Directors at Duale Hochschule Baden-Württemberg, VFA (Verband Forschender Arzneimittelhersteller e.V.) und BDI (Bundesverband der Deutschen Industrie)
Dr. rer. nat. Ralf D. Hess
Principal Management Consultant und Member of the Task Force
ENTOURAGE GmbH, München und ENTOURAGE PHARMA AG, Basel
Working on device and drug regulatory and quality (GxP/ISO) compliance. The customer service portfolio varies from manufacturers of small molecules and biological medicinal products to medical device companies and vaccine manufacturers to immunohistochemical, immunological, molecular biological and serological diagnostic laboratories. Operating worldwide as an auditor in the area of GxP/ISO with long-time experience in FDA remediation projects as well as in the regulatory development of combination products (drug device products).
Dr. Dieter Russmann MD
Vice President Customer Strategy at Kinapse Ltd. London, Beirat Universität Freiburg
Dr. Jürgen Regenold
pharmacist and PhD in pharmacology from the University of Freiburg
Since 1994 CEO of Dr. Regenold GmbH in Badenweiler, a service provider specialized in regulatory affairs